Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Director departure
Notes underwriting agrmnt
BIOLARGO, INC. (BLGO) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 8-K Investor presentation
Docs: "Slide deck presentation"
06/12/2023 8-K Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits  Interactive Data
06/09/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Transcript of Annual Stockholder Meeting"
06/06/2023 8-K Investor presentation
Docs: "Presentation slides"
05/18/2023 8-K Investor presentation
Docs: "Slide deck presentation"
05/09/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Interview transcript"
04/04/2023 8-K Investor presentation
Docs: "Slide deck presentation"
03/27/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "BioLargo, Inc. 2023 Engagement Extension Agreement"
12/19/2022 8-K Quarterly results
11/03/2022 8-K Quarterly results
10/31/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "BioLargo Sets Another New Quarterly Revenue Record Westminster, CA – October 26, 2022 – BioLargo, Inc. , a developer of sustainable cleantech technologies and full-service environmental engineering company, today announced that it has set a new quarterly revenue record, and provided a snapshot of continued business developments. BioLargo’s President and CEO Dennis P. Calvert commented, “It is remarkable that we were able to improve on Q2’s record-breaking results, and that because of our Q3 performance we have also locked in a record growth rate for the entire year. We are proud of these accomplishments, but not yet satisfied because we believe that we have still just scratched the surface of the commercial opportunities ahead. We intend to continue this trend of meaningful growth, and we ..."
08/05/2022 8-K Quarterly results
06/07/2022 8-K Quarterly results
06/02/2022 8-K Quarterly results
05/19/2022 8-K Quarterly results
04/20/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "BioLargo Continues Growth Trend by Breaking Quarterly Revenue Record"
04/04/2022 8-K Investor presentation
Docs: "BioLargo Annual Report for 2021 Highlights Active Commercial Catalysts, Expanding Partnerships, and Improved Balance Sheet Westminster, CA – March 31, 2022 – BioLargo, Inc. , a developer of sustainable cleantech technologies and full-service environmental engineering company, filed its Annual Report on Form 10-K with the SEC today for the year ended December 31, 2021 . Here, the company has provided highlights of its financial, commercial, and developmental advancements throughout the past year. BioLargo will hold an investor webcast on Monday, April 4, 2022, at 1:30 pm Pacific / 4:30 pm Eastern, at the following link, open to the public: https://www.webcaster4.com/Webcast/Page/2448/44944 “The past year was pivotal for BioLargo,” said the company’s CEO, Dennis P. Calvert. “The credibility ...",
"Presentation slides"
03/24/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "BioLargo, Inc. 2022 Engagement Extension Agreement This Engagement Extension Agreement references the Engagement Agreement and Scope Letter dated February 1, 2008 by and between CFO 911 ” and BioLargo, Inc. , and written extensions to the Agreement , pursuant to which Charles K. Dargan II has been serving as the Company’s Chief Financial Officer. The parties desire to extend the terms of the prior agreements for a period of one year, pursuant to the terms of this Extension. The 2008 Agreement, the Prior Extensions and this Extension are collectively referred to herein as the “Agreement”. Except as expressly amended or modified herein, all terms and conditions set forth in the 2008 Agreement and Prior Extensions are incorporated herein by this reference and continue to be in full force and ..."
03/08/2022 8-K Quarterly results
06/17/2021 8-K Quarterly results
06/15/2021 8-K Quarterly results
05/19/2021 8-K Quarterly results
03/31/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "BioLargo Year End 2020 Earnings Results Webcast and Conference Call Wednesday, March 31, 2021 - 5:00 PM Eastern Time Westminster, CA – March 30, 2021 – BioLargo, Inc. , a developer of sustainable clean- technologies and full-service environmental engineering company to host investor webcast and conference call on Wednesday March 31, 2021, at 2:00 pm PST / 5:00 pm EST, open to the public. BioLargo will issue full-year 2020 results after the market closes on Tuesday, March 30, 2021. A webcast and conference call will be held to review the company’s financial results, discuss recent events, and conduct a question-and-answer session. The webcast, accompanying presentation materials, and teleconference replay will be made available on the Investor Relations section of BioLargo’s website at biol...",
"BioLargo 2020 Annual Report Highlights Expanding Commercial Traction for its Cleantech Technologies, Record Revenue Growth and Improved Balance Sheet",
"Presentation slides"
03/05/2021 8-K Quarterly results
01/25/2021 8-K Investor presentation
Docs: "BioLargo Generates Record Revenue in 2020"
12/21/2020 8-K Investor presentation
Docs: "BioLargo to Report Record Revenues in Fourth Quarter of 2020"
08/03/2020 8-K Quarterly results
07/28/2020 8-K Quarterly results
07/07/2020 8-K Quarterly results
03/31/2020 8-K Investor presentation
Docs: "BioLargo 2019 Annual Report Highlights Record Revenues, New Channel Partnerships, and Commercialization Milestones Iodine Solutions in the Works to Help Combat COVID-19 Crisis Westminster, CA – March 31, 2020 – BioLargo, Inc. , an innovator of technology-based products and environmental engineering solutions provider, filed with the SEC its 2019 Annual Report on Form 10-K . Highlights from the annual report are provided here along with commentary on how the company is working to help combat the COVID-19 crisis through the development and deployment of hand sanitizers, design for a low cost emergency ventilator , and exploring expanded uses for its FDA 510 cleared Wound Irrigation Solution and other iodine-based product opportunities. Key financial highlights from the 2019 annual report inc..."
03/31/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Registration Rights Agreement, by and between BioLargo, Inc. and Lincoln Park Capital Fund, LLC",
"Purchase Agreement, by and between BioLargo, Inc. and Lincoln Park Capital Fund, LLC"
03/03/2020 8-K Quarterly results
02/26/2020 8-K Quarterly results
02/12/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy